Bioaffinity Technologies Stock Statistic Functions Beta
| BIAF Stock | USD 1.14 0.03 2.56% |
| Symbol |
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on bioAffinity Technologies correlated with the market. If Beta is less than 0 BioAffinity Technologies generally moves in the opposite direction as compared to the market. If BioAffinity Technologies Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one bioAffinity Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioAffinity Technologies is generally in the same direction as the market. If Beta > 1 BioAffinity Technologies moves generally in the same direction as, but more than the movement of the benchmark.
BioAffinity Technologies Technical Analysis Modules
Most technical analysis of BioAffinity Technologies help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioAffinity from various momentum indicators to cycle indicators. When you analyze BioAffinity charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About BioAffinity Technologies Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of bioAffinity Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of bioAffinity Technologies based on widely used predictive technical indicators. In general, we focus on analyzing BioAffinity Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioAffinity Technologies's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of BioAffinity Technologies's intrinsic value. In addition to deriving basic predictive indicators for BioAffinity Technologies, we also check how macroeconomic factors affect BioAffinity Technologies price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 2.88 | 6.06 | 5.45 | 5.73 | Days Of Inventory On Hand | 3.88 | 1.68 | 1.94 | 1.84 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioAffinity Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioAffinity Technologies' short interest history, or implied volatility extrapolated from BioAffinity Technologies options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Sold over 30 shares | |
 | Industrials ETFs Invested over 200 shares | |
| Sector ETFs Sold over 100 shares | |
 | ESG Investing Invested few shares | |
 | Climate Change Invested over 100 shares | |
 | Social Domain Invested over 100 shares | |
 | Cash Cows Invested over 100 shares | |
 | Tech Growth Invested over 200 shares | |
 | Gold and Gold Mining Invested over 200 shares | |
 | Hedge Favorites Invested over 500 shares | |
 | Millennials Best Invested over 90 shares | |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioAffinity Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. For more detail on how to invest in BioAffinity Stock please use our How to Invest in BioAffinity Technologies guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Can Biotechnology industry sustain growth momentum? Does BioAffinity have expansion opportunities? Factors like these will boost the valuation of BioAffinity Technologies. Projected growth potential of BioAffinity fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating BioAffinity Technologies demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (13.83) | Revenue Per Share | Quarterly Revenue Growth (0.39) | Return On Assets | Return On Equity |
The market value of bioAffinity Technologies is measured differently than its book value, which is the value of BioAffinity that is recorded on the company's balance sheet. Investors also form their own opinion of BioAffinity Technologies' value that differs from its market value or its book value, called intrinsic value, which is BioAffinity Technologies' true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because BioAffinity Technologies' market value can be influenced by many factors that don't directly affect BioAffinity Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between BioAffinity Technologies' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BioAffinity Technologies should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, BioAffinity Technologies' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.